Macquarie Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-178
| Closed | -$21K | – | 1935 |
|
|
2022
Q3 | $21K | Sell |
178
-220
| -55% | -$26K | ﹤0.01% | 2171 |
|
|
2022
Q2 | $19K | Hold |
398
| – | – | ﹤0.01% | 2324 |
|
|
2022
Q1 | $28 | Hold |
398
| – | – | ﹤0.01% | 2306 |
|
|
2021
Q4 | $30K | Hold |
398
| – | – | ﹤0.01% | 2298 |
|
|
2021
Q3 | $23K | Hold |
398
| – | – | ﹤0.01% | 2419 |
|
|
2021
Q2 | $18K | Hold |
398
| – | – | ﹤0.01% | 2377 |
|
|
2021
Q1 | $20K | Sell |
398
-105
| -21% | -$5.28K | ﹤0.01% | 2280 |
|
|
2020
Q4 | $21K | Hold |
503
| – | – | ﹤0.01% | 2211 |
|
|
2020
Q3 | $23K | Hold |
503
| – | – | ﹤0.01% | 2137 |
|
|
2020
Q2 | $25K | Buy |
+503
| New | +$25K | ﹤0.01% | 2119 |
|
|
2018
Q1 | – | Sell |
-2,700
| Closed | -$158K | – | 2222 |
|
|
2017
Q4 | $158K | Buy |
2,700
+2,100
| +350% | +$123K | ﹤0.01% | 1797 |
|
|
2017
Q3 | $28K | Buy |
+600
| New | +$28K | ﹤0.01% | 2065 |
|